Mizuho Securities analyst Anthony Petrone reiterated a Buy rating on Establishment Labs Holdings today and set a price target of $70.00. The company’s shares closed last Friday at $41.43.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
According to TipRanks, Petrone is a 4-star analyst with an average return of 5.0% and a 48.12% success rate. Petrone covers the Healthcare sector, focusing on stocks such as Teleflex, Resmed, and Medtronic.
Currently, the analyst consensus on Establishment Labs Holdings is a Strong Buy with an average price target of $55.63.
Based on Establishment Labs Holdings’ latest earnings release for the quarter ending June 30, the company reported a quarterly revenue of $51.3 million and a GAAP net loss of $16.59 million. In comparison, last year the company earned a revenue of $44.12 million and had a GAAP net loss of $17.18 million
Based on the recent corporate insider activity of 36 insiders, corporate insider sentiment is positive on the stock. This means that over the past quarter there has been an increase of insiders buying their shares of ESTA in relation to earlier this year. Most recently, in August 2025, NICHOLAS SHERIDAN LEWIN, a Director at ESTA bought 2,600.00 shares for a total of $98,410.00.
Read More on ESTA:
Disclaimer & DisclosureReport an Issue
- Establishment Labs Amends Credit Agreement with Oaktree
- Establishment Labs initiated with a Buy at Canaccord
- Establishment Labs Reports Strong Growth Amid Challenges
- Establishment Labs Reports Strong Q2 2025 Revenue Growth
- Establishment Labs Holdings: Strong Financial Performance and Promising Market Trends Justify Buy Rating